J Stroke.  2015 May;17(2):199-209. 10.5853/jos.2015.17.2.199.

A Novel Computerized Clinical Decision Support System for Treating Thrombolysis in Patients with Acute Ischemic Stroke

Affiliations
  • 1Clinical Research Center, Asan Medical Center, Seoul, Korea.
  • 2Department of Neurology, Seoul National University Hospital, Seoul, Korea.
  • 3Department of Neurology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
  • 4Department of Neurology, Eulji General Hospital, Eulji University, Seoul, Korea.
  • 5Department of Neurology, Seoul Medical Center, Seoul, Korea.
  • 6Department of Neurology, Soonchunhyang University Hospital Seoul, Seoul, Korea.
  • 7Department of Neurology, Eulji University Hospital, Daejeon, Korea.
  • 8Department of Neurology, Ilsan Paik Hospital, Inje University, Goyang, Korea.
  • 9Human-Computer Interaction Lab, Department of Computer Science and Engineering, Seoul National University, Seoul, Korea.
  • 10Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 11Department of Biostatistics, Korea University College of Medicine, Seoul, Korea. jyleeuf@korea.ac.kr

Abstract

BACKGROUND AND PURPOSE
Thrombolysis is underused in acute ischemic stroke, mainly due to the reluctance of physicians to treat thrombolysis patients. However, a computerized clinical decision support system can help physicians to develop individualized stroke treatments.
METHODS
A consecutive series of 958 patients, hospitalized within 12 hours of ischemic stroke onset from a representative clinical center in Korea, was used to establish a prognostic model. Multivariable logistic regression was used to develop the model for global and safety outcomes. An external validation of developed model was performed using 954 patients data obtained from 5 university hospitals or regional stroke centers.
RESULTS
Final global outcome predictors were age; previous modified Rankin scale score; initial National Institutes of Health Stroke Scale (NIHSS) score; previous stroke; diabetes; prior use of antiplatelet treatment, antihypertensive drugs, and statins; lacunae; thrombolysis; onset to treatment time; and systolic blood pressure. Final safety outcome predictors were age, initial NIHSS score, thrombolysis, onset to treatment time, systolic blood pressure, and glucose level. The discriminative ability of the prognostic model showed a C-statistic of 0.89 and 0.84 for the global and safety outcomes, respectively. Internal and external validation showed similar C-statistic results. After updating the model, calibration slopes were corrected from 0.68 to 1.0 and from 0.96 to 1.0 for the global and safety outcome models, respectively.
CONCLUSIONS
A novel computerized outcome prediction model for thrombolysis after ischemic stroke was developed using large amounts of clinical information. After external validation and updating, the model's performance was deemed clinically satisfactory.

Keyword

Acute ischemic stroke; Clinical decision support system; Prediction model; Thrombolysis

MeSH Terms

Antihypertensive Agents
Blood Pressure
Calibration
Glucose
Hospitals, University
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Korea
Logistic Models
National Institutes of Health (U.S.)
Stroke*
Antihypertensive Agents
Glucose
Full Text Links
  • JOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr